Clinical Trial Update: D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial exploring D-Cycloserine to augment behavior therapy for body dysmorphic disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Body Dysmorphic Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Body Dysmorphic Disorder | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-03-15